KRISTEN MELERVEY: Open Payments
NPI 1871214452 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,606 in 126 payments from 20 companies in 2025. Trend: 2023 $1,377 · 2024 $3,097 · 2025 $2,606
Food & beverage: $2,606
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $333 |
| Neurocrine BioSciences, Inc. | 9 | $282 |
| ABBVIE INC. | 18 | $236 |
| Lundbeck LLC | 10 | $228 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $215 |
| Vanda Pharmaceuticals Inc. | 7 | $189 |
| Otsuka America Pharmaceutical, Inc. | 8 | $171 |
| Collegium Pharmaceutical, Inc. | 9 | $158 |
| Axsome Therapeutics, Inc. | 8 | $150 |
| Alkermes, Inc. | 8 | $135 |
Products named: REXULTI, INGREZZA, INVEGA SUSTENNA, VRAYLAR, CAPLYTA, FANAPT, Jornay PM, Auvelity.
Industry payments across FL — which companies pay providers there.
